ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Ophthalmology

Top Ophthalmology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATHERINE LOFTFIELD MD

Ophthalmology

7,059

$460K

767
723 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 61%

$65
Average prescription price

Avg: $71

MICHAEL MORGAN M.D.

Ophthalmology

5,204

$273K

728
685 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 61%

$52
Average prescription price

Avg: $71

CHRISTOPHER GRENIER M.D.

Ophthalmology

5,047

$310K

751
707 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 61%

$61
Average prescription price

Avg: $71

BARRY LEADER M.D.

Ophthalmology

4,666

$361K

955
869 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 61%

$77
Average prescription price

Avg: $71

THOMAS PARKER M.D.

Ophthalmology

4,632

$349K

1016
927 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $71

RAMESH AYYALA M.D.

Ophthalmology

4,570

$342K

680
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $71

GERALD BROUSSARD MD

Ophthalmology

4,311

$386K

853
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 61%

$90
Average prescription price

Avg: $71

CHARLES WILLIAMSON MD

Ophthalmology

4,157

$302K

1207
1005 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

78%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $71

WILLIAM WILLIAMSON MD

Ophthalmology

4,049

$306K

910
785 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 61%

$76
Average prescription price

Avg: $71

CHANPING LIANG M.D.

Ophthalmology

3,896

$223K

550
422 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 61%

$57
Average prescription price

Avg: $71

JOHN COOKSEY M.D.

Ophthalmology

3,745

$222K

803
750 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 61%

$59
Average prescription price

Avg: $71

JOSEPH BARRON M.D.

Ophthalmology

3,646

$239K

666
621 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 61%

$66
Average prescription price

Avg: $71

EDWARD STAHEL M.D.

Ophthalmology

3,513

$199K

559
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 61%

$57
Average prescription price

Avg: $71

VIET BUI MD

Ophthalmology

3,452

$253K

575
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $71

STEPHEN BREAUD MD

Ophthalmology

3,442

$182K

855
751 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

81%
prescriptions for brand name drugs

Avg: 61%

$53
Average prescription price

Avg: $71

GARY LUFFEY M.D.

Ophthalmology

3,319

$368K

609
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

91%
prescriptions for brand name drugs

Avg: 61%

$111
Average prescription price

Avg: $71

NEIL NOTAROBERTO M.D.

Ophthalmology

3,152

$221K

789
695 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 61%

$70
Average prescription price

Avg: $71

HENRY HALEY M.D.

Ophthalmology

3,064

$235K

823
697 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 61%

$77
Average prescription price

Avg: $71

JOHN AZAR MD

Ophthalmology

3,063

$307K

464
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

75%
prescriptions for brand name drugs

Avg: 61%

$100
Average prescription price

Avg: $71

QUENTIN FALGOUST MD

Ophthalmology

3,000

$210K

674
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 61%

$70
Average prescription price

Avg: $71

PHILIP EHRLICH MD

Ophthalmology

2,891

$232K

432
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 61%

$80
Average prescription price

Avg: $71

EDWARD LANGLOW MD

Ophthalmology

2,883

$140K

392
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 61%

$48
Average prescription price

Avg: $71

BERNARD PATTY MD

Ophthalmology

2,850

$204K

495
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 61%

$72
Average prescription price

Avg: $71

ROBERT CASANOVA M.D.

Ophthalmology

2,816

$194K

363
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $71

RAYMOND HAIK M.D.

Ophthalmology

2,709

$148K

648
579 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 61%

$55
Average prescription price

Avg: $71

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank